Currently, there are no medications specifically approved for the underlying fat accumulation of NAFLD
The results were not performed in parallel and originate from various in vitro assays
From an expert perspective, the development of GLP-1RAs has marked a pivotal advancement by targeting key pathophysiological mechanisms such as hepatic lipid metabolism, inflammation, and fibrosis
Our provider will review and adjust as needed based on your medical history
Aromatase inhibitors, a common class of breast cancer medication, seem to limit the effectiveness of GLP-1 drugs, perhaps due to their anti-estrogen effects
According to the result of the research of Amini and his colleagues among 70 euglycemic women with PCOS, who received a sage extract supplementation for eight weeks, it was noted that the participants communicated a decline in BMI and huge gains in the area of insulin resistance and fasting insulin level [204]